Page last updated: 2024-08-23

simvastatin and Hypertension, Renal

simvastatin has been researched along with Hypertension, Renal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bae, E; Han, SW; Kim, JE; Kim, YS; Lee, S; Moon, JJ; Park, DJ; Yang, SH; Yu, MY1
Agrotis, A1
Chade, AR; Grande, JP; Krier, JD; Lerman, A; Lerman, LO; Zhu, XY1
Liu, DH; Tang, YB; Wang, M; Xue, SJ; Zhang, Z1
DellĂȘ, H; Fujihara, CK; Malheiros, DM; Mantovani, E; Mattar, AL; Noronha, IL; Rodrigues, LT; Vieira, JM; Zatz, R1

Other Studies

5 other study(ies) available for simvastatin and Hypertension, Renal

ArticleYear
Renoprotective Effect of KLF2 on Glomerular Endothelial Dysfunction in Hypertensive Nephropathy.
    Cells, 2022, 02-22, Volume: 11, Issue:5

    Topics: Angiotensin II; Animals; Atherosclerosis; Endothelial Cells; Fibrosis; Humans; Hypertension, Renal; Interleukin-18; Kruppel-Like Transcription Factors; Mice; Nephritis; RNA, Messenger; Simvastatin; Transcription Factors

2022
Simvastatin, an inhibitor of epithelial-to-mesenchymal transition in experimental atherosclerotic renovascular disease?
    Journal of hypertension, 2008, Volume: 26, Issue:8

    Topics: Animals; Atherosclerosis; Epithelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Mesenchymal Stem Cells; Simvastatin

2008
Simvastatin abates development of renal fibrosis in experimental renovascular disease.
    Journal of hypertension, 2008, Volume: 26, Issue:8

    Topics: Animals; Atherosclerosis; Blood Pressure; Disease Models, Animal; Epithelial Cells; Fibrosis; Glomerular Filtration Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Mesenchymal Stem Cells; Renal Artery Obstruction; Renal Circulation; Simvastatin; Sus scrofa

2008
Simvastatin ameliorates angiotensin II-induced endothelial dysfunction through restoration of Rho-BH4-eNOS-NO pathway.
    Cardiovascular drugs and therapy, 2012, Volume: 26, Issue:1

    Topics: Acetylcholine; Angiotensin II; Animals; Biopterins; Blood Pressure; Carotid Arteries; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; GTP Cyclohydrolase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Simvastatin; Vasodilation

2012
Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease.
    Nephron. Physiology, 2005, Volume: 101, Issue:4

    Topics: Albuminuria; Animals; Cell Division; Chemokine CCL2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Enzyme Inhibitors; Extracellular Matrix; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Lymphocytes; Macrophages; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; RNA, Messenger; Simvastatin; Sodium Chloride; Transforming Growth Factor beta

2005